Fishman Oncology Center- Rambam shared a post on LinkedIn:
“Proud to share our contribution to the European Association for Cancer Research (EACR) 2026 Congress.
Cancer during pregnancy carries a major healthcare impact. Following presenting the epidemiological data at American Society of Clinical Oncology (ASCO) 2026, Professor Irit Ben-Aharon shared the pre-clinical research conducted in her laboratory at the RTICC, Technion – Israel Institute of Technology, at the EACR 2026 meeting.
The presented data indicate that chemotherapy crosses the placenta and induces epigenetic alterations in some embryos. Moreover, Orly Abramovich, a PhD student in the lab, presented her work on studying the short and long-term outcomes of in utero exposure to chemotherapy.”
More posts about EARC.